Advaxis and Personalis Announce Research Agreement to Deploy ImmunoID NeXT Platform in the ADXS-503 Clinical Program Read more
Ligand Agrees to Acquire Core Assets, Partnered Programs and Ion Channel Technologies from Icagen Read more
LakePharma and NJ Bio Form Strategic Alliance to Provide Streamlined Antibody-Drug Conjugate Services Read more
ReForm Biologics and MilliporeSigma Announce a Licensing Agreement for Excipient Development and Commercialization Read more
Biohaven’s Troriluzole Study For Generalized Anxiety Disorder (GAD) Misses Primary Endpoint Read more
FDA Grants Priority Review for Kite’s KTE-X19 BLA in Relapsed or Refractory Mantle Cell Lymphoma Read more
AI in Drug Discovery to host panel discussion on “The AI Paradigm Shift – is it just a hype?” Read more